T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
about
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cellsRecruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signalingThe prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activationThe lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cellsTAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell deathPIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunitTRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activationStimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaBCD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survivalTumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligandTumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activationTRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosisThe ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin APleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) familyTWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosisActivation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activationEpigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemiaTumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activationCD30 prevents T-cell responses to non-lymphoid tissues.CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.Role of TNF in lymphocyte-mediated cytotoxicity.The role of CD30 in atopic disease.Translocations involving anaplastic lymphoma kinase (ALK).Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signalingThe oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells.Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45).Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnanciesAssociation of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritisNeed for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.TNF superfamily: costimulation and clinical applicationsCD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin.CD30: an important new target in hematologic malignancies.
P2860
Q22009150-6C076077-DE0C-40D3-B170-3F46205F5A91Q22253441-1450648B-BCA0-4589-8D5C-C57445BDA5C9Q22254032-7AFF8106-F9D1-402B-849D-571A120A5D03Q22254033-1C5ABE73-33CF-47E5-B7E5-E962830FB5CEQ22254092-1237EAF7-988B-4902-9CF6-2F69169D31E2Q24292903-319F1763-B8A0-40F5-B625-00E7A1CB6DDDQ24313308-25618D67-762E-484E-A94E-E682E5F922FEQ24316194-5EEC614A-89F7-4E18-B9C6-7A474B8CD085Q24564927-196657ED-94D3-481C-AFB1-6A7C6038D188Q24605401-455F8F92-8274-4CEE-8BFF-3699963238B9Q24642851-1C6292F4-261B-4781-9211-2D842BC437A0Q24647213-8F91B5D6-89FC-4572-909F-29E49B3741A3Q24679579-C2070D57-ADB2-48F2-B44C-C74523524F6EQ28138885-ACF0DAA6-65DF-432C-89AF-841A7D1556EFQ28141467-C11A4F49-78AA-4771-BC55-798D90CFCEE5Q28208696-61AFD859-483D-45BF-BB26-6D4219072F35Q28257134-ACB001A6-1F1D-4D78-9916-482AD483ED5AQ28263653-0D01046E-EFA5-41A9-ADF0-F9404C43E505Q28263993-B6EC9971-C82E-466A-8519-7C156EA89636Q28301504-63E552DF-4614-4A82-A230-C0B2CB8D6070Q33713263-6083F973-293D-4EE3-84E6-2194FA9AEFACQ33747241-E6FCADD8-B0A4-454E-AB90-3F4D3E0AA884Q33891000-FC1E08EF-3804-43F4-8644-6013209DBC7FQ33966313-D327ACC8-42C2-4849-9F87-56C6C5B2BDEDQ34291177-F9BE221D-4649-499D-BBB6-18943C48B2DEQ34405439-7733DB07-9F35-4959-B341-663166D12B20Q34428468-979927C7-8F8D-4D39-B7BA-0DCC0455E07BQ35607281-E7F79102-7EA0-4CA7-91C0-46609EFBD9B0Q35996947-6E71451E-7C99-49F1-B4CC-B457BB48FBC9Q36211163-C1765E92-65D2-4957-AA24-3EFBA73EE972Q36369373-36C6F5CB-145C-4B9D-AE8A-B38BB291AD31Q36512063-AFE58A6C-A387-4841-880D-8DA20AE988E4Q36564433-DEF76E06-73D4-4F8D-853E-D13E37B09EBCQ36566021-F9211130-C7B9-4F88-AF9F-0FFE08FBDFBEQ36569720-E644F2C1-A37C-4EA8-BF54-9A1245945709Q36771224-A49A4063-EBA8-4907-B705-FA4945B9A37FQ37266849-C7D0EBC2-C255-4863-9D78-5EBA165F8051Q37360807-604DECEB-1206-4AC3-A95B-5C5A29B29C5CQ37412853-B16670E3-2F34-4161-A39F-FBD3EB78AFA0Q37880873-81235B8C-CEB5-413C-B362-294AD2576B5A
P2860
T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
T cell receptor-dependent cell ...... or receptor-associated factors
@ast
T cell receptor-dependent cell ...... or receptor-associated factors
@en
T cell receptor-dependent cell ...... or receptor-associated factors
@nl
type
label
T cell receptor-dependent cell ...... or receptor-associated factors
@ast
T cell receptor-dependent cell ...... or receptor-associated factors
@en
T cell receptor-dependent cell ...... or receptor-associated factors
@nl
prefLabel
T cell receptor-dependent cell ...... or receptor-associated factors
@ast
T cell receptor-dependent cell ...... or receptor-associated factors
@en
T cell receptor-dependent cell ...... or receptor-associated factors
@nl
P2093
P2860
P356
P1476
T cell receptor-dependent cell ...... or receptor-associated factors
@en
P2093
P2860
P304
P356
10.1084/JEM.183.2.669
P407
P577
1996-02-01T00:00:00Z